Positive Outlook on Merus’s Petosemtamab for HNSCC with Improved Efficacy and Safety Metrics
H.C. Wainwright analyst Andrew Fein has maintained their bullish stance on MRUS stock, giving a Buy rating today.Don't Miss our Black Friday ...
Positive Outlook for Merus: Promising Data and Stable Safety Profile Boost Investment Confidence
In a report released today, Ami Fadia from Needham maintained a Buy rating on Merus (MRUS – Research Report), with a price target of ...
Pro Soccer Wire on MSN29m
The Americans Abroad Five: Is Musah Milan's key?
It was a mostly underwhelming weekend for Americans Abroad, with goal contributions hard to find among the most high-profile ...